S11E1036 Vitamin D: Repletion doses and the evidence of potential toxicity | GameChangers
Recently news suggests low vitamin D levels have been associated with increased risk of COVID-related morbidity and mortality. We know… More Details
Stay connected to the latest clinical updates, teaching strategies, and practice-ready skills – delivered in a format that fits your busy life. Learn on your schedule without sacrificing quality or depth.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update Series is included with your Pharmacist Subscription. But wait…there’s even more!
What the Pharmacist CE Subscription Includes:
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
Recently news suggests low vitamin D levels have been associated with increased risk of COVID-related morbidity and mortality. We know… More Details
Recently, Remdesivir was given Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) for use in… More Details
Buprenorphine has been shown in numerous studies to be safe and effective in opioid use disorder, yet < 10% patients… More Details
Geoff Wall, PharmD & Jamie Pitlick, PharmD discussing SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption… More Details
GameChangers: In this episode, we describe the latest information concerning hypercoagulability with COVID-19 infection. In this episode, we describe the… More Details